Overview
Glucagonoma is a rare neuroendocrine tumor characterized by excessive glucagon production, leading to a constellation of symptoms including diabetes mellitus, weight loss, and a characteristic rash known as necrolytic migratory erythema 1.Diagnosis
Elevated plasma glucagon levels 1.
Identification of glucagon-secreting tumors through imaging (e.g., CT, MRI) 1.
Chromatographic analysis may reveal genuine glucagon rather than larger immunoreactive forms 1.
Absence of overt diabetes or hyperglycemia despite elevated glucagon levels 1.Management
Surgical resection of the tumor when feasible 1.
Supportive care including glucose monitoring and management 1.
No specific drug doses mentioned for glucagonoma management in the provided abstracts 1.Special Populations
No specific data provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.Key Recommendations
Confirm diagnosis through elevated plasma glucagon levels and imaging to identify the source tumor (Evidence: Moderate) 1.
Prioritize surgical intervention for localized tumors to achieve potential cure (Evidence: Expert opinion) 1.
Manage metabolic complications symptomatically, focusing on glucose control without specific pharmacological interventions detailed in the abstracts (Evidence: Expert opinion) 1.References
1 Torre L, Vazquez JA, Blázquez E. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma. Hormone research 1986. link